Holen Sie sich die Stockscreener-App
96.03
0.48%
0.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$95.57
Offen:
$96.33
24-Stunden-Volumen:
1.47M
Relative Volume:
0.98
Marktkapitalisierung:
$10.89B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
40.86
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
-5.47%
1M Leistung:
-12.81%
6M Leistung:
+5.61%
1J Leistung:
-14.93%
1-Tages-Spanne:
$95.39
$97.98
1-Wochen-Bereich:
$93.70
$106.55
52-Wochen-Spanne:
$81.36
$120.39
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
96.03 | 10.84B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
New York Life Investment Management LLC Acquires 11,583 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity Unveils SLAS2026 Platforms As Valuation Gap Attracts Attention - Sahm
Can Revvity Inc. outperform in the next rallyJuly 2025 Gainers & Reliable Entry Point Trade Alerts - mfd.ru
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - MSN
Will Revvity Inc. stock see insider buyingSwing Trade & Capital Efficiency Focused Ideas - mfd.ru
Revvity boosts momentum at SLAS2026 with full session lineup - Traders Union
Optical Preclinical Imaging Market size to hit $982.8 Million - openPR.com
Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside - Sahm
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization - GlobeNewswire Inc.
Revvity showcases industry insights at SLAS2026 opening - Traders Union
Winners Losers: Can Revvity Inc outperform in the next rally2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Diamond Hill Capital Management Inc. Acquires New Holdings in Revvity Inc. $RVTY - MarketBeat
Downgrade Watch: Is Revvity Inc showing insider buyingInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Nigeria
Revvity delivers Q4 beat as earnings and revenue top forecasts - MSN
Assessing Revvity (RVTY) Valuation After New SLAS2026 Lab Automation Launches - Sahm
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity Inc (RVTY) Shares Gap Down to $100.55 on Feb 5 - GuruFocus
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Yahoo Finance
Truist Financial Corp Decreases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Receives a Buy from UBS - The Globe and Mail
Behavioral Patterns of RVTY and Institutional Flows - Stock Traders Daily
Revvity Inc.: How a Quiet Lab-Tech Powerhouse Is Rewiring the Future of Diagnostics and Drug Discove - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC), Revvity (RVTY) and Biogen (BIIB) - The Globe and Mail
Cowen & Co. Maintains Hold on Revvity (RVTY) Feb 03, 2026 - Meyka
Analysts Offer Insights on Healthcare Companies: Revvity (RVTY) and Aktis Oncology, Inc. (AKTS) - The Globe and Mail
Revvity stock price target raised to $124 from $120 at TD Cowen - Investing.com Canada
Revvity stock rating reiterated at Overweight by KeyBanc By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
JP Morgan Raises Revvity (RVTY) Price Target to $105.00 | RVTY S - GuruFocus
Revvity: Close To A Buy, Not Quite There (NYSE:RVTY) - Seeking Alpha
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE:RVTY) Shares Track S&P 500 as Index Benchmarks Hold - Kalkine Media
Here's Why Revvity (RVTY) is a Strong Momentum Stock - sharewise.com
Revvity stock price target raised to $124 from $120 at TD Cowen By Investing.com - Investing.com India
TD Cowen Maintains 'Buy' Rating on RVTY, Raises Price Target to $124 | RVTY Stock News - GuruFocus
Revvity (NYSE:RVTY) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Transcript: Q 2026 Earnings Conference Call - Benzinga
Revvity (RVTY) Receives Price Target Boost from Evercore ISI Gro - GuruFocus
Barclays Maintains Overweight Rating on RVTY, Raises Price Targe - GuruFocus
Wells Fargo Raises Price Target for RVTY, Maintains Equal-Weight Rating | RVTY Stock News - GuruFocus
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
Wells Fargo & Company Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (RVTY) Maintains Hold Rating, Price Target Raised to $10 - GuruFocus
Wells Fargo Adjusts Price Target on Revvity to $110 From $107 - marketscreener.com
TD Cowen Adjusts Revvity PT to $124 From $120 - marketscreener.com
Revvity, Inc. (NYSE:RVTY) Q4 2025 earnings call transcript - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2025 Earnings Call Transcript - Insider Monkey
Baird Adjusts Price Target on Revvity to $129 From $123 - marketscreener.com
Raymond James Adjusts Price Target on Revvity to $132 From $115 - marketscreener.com
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):